Q4 Inc. Reports Strong Progress in Second Quarter 2023 Results
Q4 Inc. (TSX:QFOR) (“Q4” or the “Company”), the leading capital markets access platform, today announced its financial results for the three and six months period ended June 30, 2023. QFOR reports in U.S. dollars and in accordance with International Financial Reporting Standards (“IFRS”).
Q2 2023 Year-over-Year Financial Highlights
- Revenue of $15.1 million, up 10%;
- Annual recurring revenue1 (“ARR”) of $55.8 million, up 4.5%;
- Annual recurring revenue per account (“ARPA“) of $20,859, up 12%;
- Gross margin of 68.3%, up 1180 basis points;
- Adjusted EBITDA2 of $(3.8) million compared with $(8.7) million, an improvement of 56%;
- Adjusted EBITDA2 loss per share $(0.09), an improvement of $0.13 per share;
- Net loss of $(6.1) million, an improvement of $5.4 million; and
- Net loss per share of $(0.15), a $0.14 per share improvement.
“During Q2, and throughout the last twelve months, the innovations coming from our platform strategy drove increased product adoption, ARPA growth and client loyalty,” said Darrell Heaps, Founder and CEO of Q4 Inc. “For investors, the successful execution of this expansion sales strategy offers confidence and visibility for future quarters. Major structural changes have been put in place over the last year which have reduced operating costs and driven significant margin improvement. We expect to exit 2023 with gross margin in the mid 70’s compared with 59% for the full year 2022.”
Q2 2023 Operational Highlights
- Over 2,000 clients and agencies active on the Q4 Platform in Q2, gaining new and unique insights while improving workflow;
- Announced the appointment of Keith Reed as Chief Operating Officer and Tim Stahl as Chief Revenue Officer;
- Unveiled new brand and visual identity, positioning Q4 as the leading capital markets access platform;
- Launched Earnings Lifecycle on the Q4 Platform, the market’s only application to streamline the planning, execution, and impact of quarterly disclosures;
- Introduced first-of-its-kind Event Management Application to the Q4 Platform, providing new IR event management technology for virtual event planning;
- Enhanced institutional targeting as part of the Engagement Analytics Suite, bringing new insights to clients that uncover untapped investor opportunities;
- Announced progress on pioneering generative artificial intelligence (“AI”) on the Q4 Platform that is purpose built for IR;
- More than 85,000 new Q4 investor accounts created during the three month period, up more than 50% since the end of 2022. As of June 30th, more than 370,000 investors have signed up for this platform service;
- More than 16 million unique investors access Q4’s network of IR websites every month; and
- Available liquidity of $44.2 million at the end of June 2023, including $21.7 million in cash and an available credit facility of $22.5 million which remains undrawn.
“By harnessing our vast amounts of proprietary data, coupled with the power of generative AI, we are transforming the investor relations workflow and solidifying our position as the leading capital markets access platform,” said Darrell Heaps. “This is what differentiates the Q4 platform and delivers unmatched value to our clients.”
“The progress made by our team in Q2 represents another significant stride towards sustained profitable growth,” commented Donna de Winter, CFO of Q4 Inc. “Looking ahead to the second half of 2023, irrespective of broader capital markets activity, we expect continued revenue momentum and margin expansion. The deliberate actions we have taken to significantly lower our operating expenses are improving our visibility to both positive EBITDA and cash flow in 2023.”
Webcast Information
Q4 will host a webcast to discuss the Company's financial results at 9:30 am ET on Wednesday, August 9, 2023. Participants can register here in advance or access the webcast live. Supplemental materials will be available at least fifteen minutes prior to the start of the event. A replay of the webcast will be available at investors.q4inc.com shortly after the event concludes.
Audience questions will be taken real-time via the Q4 Platform. Investors can also submit their questions in advance to ir@q4inc.com or via our IR website. We will do our best to respond to your questions either on the webcast, if time permits or shortly thereafter. We appreciate your interest.
Q4's unaudited interim consolidated financial statements and management's discussion and analysis for the three months ended March 31, 2023 will be available on Q4's IR website and will be filed on SEDAR at www.sedar.com.
Second Quarter 2023 Results
Selected Financial Measures
Revenue |
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
||||||
|
2023 |
2022 |
Change |
Change |
|
2023 |
2022 |
Change |
Change |
(USD, in thousands) |
$ |
$ |
$ |
% |
|
$ |
$ |
$ |
% |
Capital markets platform |
13,569 |
12,541 |
1,028 |
8.2% |
|
26,751 |
25,405 |
1,346 |
5.3% |
Platform services |
1,520 |
1,196 |
324 |
27.1% |
|
2,818 |
2,260 |
558 |
24.7% |
Other |
9 |
16 |
(7) |
|
|
28 |
34 |
(6) |
|
Total revenue |
15,098 |
13,753 |
1,345 |
9.8% |
|
29,597 |
27,699 |
1,898 |
6.9% |
Gross profit |
10,318 |
7,777 |
2,541 |
32.7% |
|
19,804 |
15,783 |
4,021 |
25.5% |
Percentage of total revenue |
68.3% |
56.5% |
|
66.9% |
57.0% |
|
Key Performance Indicators |
||||||||
(in USD) |
June 30, 2023 |
June 30, 2022 |
Change |
Change |
||||
Annual Recurring Revenue (in millions) |
$ |
55.8 |
$ |
53.3 |
$ |
2.5 |
4.5 % |
|
Average Recurring Revenue per Account |
$ |
20,859 |
$ |
18,642 |
$ |
2,217 |
11.9% |
Results of Operations
The following table outlines our consolidated statement of loss and comprehensive loss for the three and six months ended June 30, 2023 and 2022:
|
Three Months Ended |
|
Six Months Ended |
||
|
June 30, |
|
June 30, |
||
|
2023 |
2022 |
|
2023 |
2022 |
(USD, in thousands) |
$ |
$ |
|
$ |
$ |
Revenue |
15,098 |
13,753 |
|
29,597 |
27,699 |
Direct cost of revenue |
4,780 |
5,976 |
|
9,793 |
11,916 |
Gross profit |
10,318 |
7,777 |
|
19,804 |
15,783 |
Operating Expenses |
|
|
|
|
|
Sales and marketing |
4,711 |
6,505 |
|
9,591 |
11,649 |
Research and development |
4,123 |
4,992 |
|
8,422 |
9,122 |
General and administrative |
6,039 |
5,777 |
|
11,565 |
11,548 |
Depreciation and amortization |
903 |
914 |
|
1,844 |
1,815 |
Foreign exchange (gain) loss |
(147) |
961 |
|
(140) |
364 |
Other expenses |
817 |
67 |
|
1,141 |
347 |
Total operating expenses |
16,446 |
19,216 |
|
32,423 |
34,845 |
Loss from operations |
(6,128) |
(11,439) |
|
(12,619) |
(19,062) |
Finance expenses |
54 |
19 |
|
66 |
41 |
Finance income |
(184) |
(3) |
|
(276) |
(6) |
Impairment loss |
— |
— |
|
634 |
— |
Gain on derivative financial instruments |
— |
(116) |
|
— |
(1,221) |
Loss before income taxes |
(5,998) |
(11,339) |
|
(13,043) |
(17,876) |
Income taxes |
59 |
110 |
|
112 |
170 |
Net loss |
(6,057) |
(11,449) |
|
(13,155) |
(18,046) |
Other comprehensive income (loss) |
|
|
|
|
|
Foreign exchange gain (loss) on foreign operations |
9 |
(52) |
|
31 |
(63) |
Net loss and comprehensive loss |
(6,048) |
(11,501) |
|
(13,124) |
(18,109) |
Basic and diluted loss per share |
(0.15) |
(0.29) |
|
(0.33) |
(0.45) |
Weighted average number of common shares outstanding - basic and diluted |
40,012 |
39,715 |
|
39,965 |
39,670 |
Key Balance Sheet Information
|
June 30, 2023 |
December 31, 2022 |
Change |
Change |
(USD, in thousands) |
$ |
$ |
$ |
% |
Cash and cash equivalents |
21,682 |
21,536 |
$146 |
0.7% |
Short-term investments |
— |
7,607 |
(7,607) |
(100.0)% |
Total assets |
62,595 |
73,832 |
(11,237) |
(15.2)% |
Total liabilities |
30,517 |
29,459 |
1,058 |
3.6% |
Total long-term liabilities |
10,732 |
8,210 |
2,522 |
30.7% |
Non-IFRS Measures and Reconciliation of Non-IFRS Measures
This press release makes reference to certain non-IFRS financial measures including key performance indicators used by management and typically used by our competitors with Software-as-a-Service (“SaaS”) business models. These measures are not recognized measures under IFRS and do not have a standardized meaning prescribed by IFRS and are therefore not necessarily comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement those IFRS financial measures by providing further understanding of our results of operations from management’s perspective. Accordingly, these measures should not be considered in isolation nor as a substitute for analysis of our financial information reported under IFRS. These non-IFRS financial measures and industry metrics are used to provide investors with supplemental measures of our operating performance and liquidity and thus highlight trends in our business that may not otherwise be apparent when relying solely on IFRS financial measures. We also believe that securities analysts, investors and other interested parties frequently use non-IFRS financial measures and industry metrics, in the evaluation of similar companies. Management also uses non-IFRS financial measures and industry metrics in order to facilitate operating performance comparisons from period to period, the preparation of annual operating budgets and forecasts and to determine components of executive compensation.
EBITDA and Adjusted EBITDA
We define EBITDA as net loss, adjusted for depreciation and amortization, finance expenses, finance income and income taxes. Adjusted EBITDA is a supplemental measure used by management to assess our financial and operating performance without regards to financing methods or capital structure. Adjusted EBITDA represents EBITDA, adjusted for the following: share-based compensation, unrealized foreign exchange (gain)/ loss, gain on derivative financial instruments, severance and related costs, impairment loss, regulatory accruals and other costs. We believe EBITDA and Adjusted EBITDA, two non-IFRS financial measures, are useful in assessing our operating cash flows as they eliminate the effects of non-cash expenses and one-time or non-recurring items recorded in the statements of loss and comprehensive loss. The Company’s definition of EBITDA and Adjusted EBITDA may be different than similarly titled measures used by other companies. The following table reconciles Adjusted EBITDA to net loss for the periods.
|
Three Months Ended |
|
Six Months Ended |
||
|
June 30, |
|
June 30, |
||
|
2023 |
2022 |
|
2023 |
2022 |
(USD, in thousands) |
$ |
$ |
|
$ |
$ |
Net loss |
(6,057) |
(11,449) |
|
(13,155) |
(18,046) |
Depreciation and amortization |
903 |
914 |
|
1,844 |
1,815 |
Finance expenses(1) |
54 |
19 |
|
66 |
41 |
Finance income |
(184) |
(3) |
|
(276) |
(6) |
Income taxes |
59 |
110 |
|
112 |
170 |
EBITDA |
(5,225) |
(10,409) |
|
(11,409) |
(16,026) |
Other adjustments |
|
|
|
|
|
Share-based compensation expense(2) |
457 |
874 |
|
883 |
1,022 |
Unrealized foreign exchange (gain) loss(3) |
(147) |
961 |
|
(140) |
364 |
Gain on derivative financial instruments(4) |
— |
(116) |
|
— |
(1,221) |
Impairment loss |
— |
— |
|
634 |
— |
Severance and related costs(5) |
545 |
— |
|
992 |
— |
Regulatory and advisory fees(6) |
607 |
— |
|
819 |
22 |
Adjusted EBITDA |
(3,763) |
(8,690) |
|
(8,221) |
(15,839) |
EBITDA loss per share |
(0.13) |
(0.26) |
|
(0.29) |
(0.40) |
Adjusted EBITDA loss per share |
(0.09) |
(0.22) |
|
(0.21) |
(0.40) |
Note: |
(1) Finance expenses are primarily related to interest and accretion of financial liabilities. |
(2) Share-based compensation includes non-cash expenditures recognized in connection with the issuance of options under our Legacy Equity Incentive Plan ("LEIP") to certain employees and directors. Options granted under the LEIP have become options under our Omnibus Equity Incentive Plan (the “Omnibus Plan”) in connection with the 2021 IPO. This amount also includes the restricted share units ("RSUs"), performance share units ("PSUs") and deferred share units ("DSUs") granted under the Omnibus Plan. |
(3) These adjustments represent the change in the value of foreign currency denominated transactions that are recorded in financial statements prior to the settlement of invoices. |
(4) These expenses relate to regulatory, consulting, advisory, and other fees that are non-operational. |
(5) Represents severance and related expenses included in G&A and other expenses. |
(6) These expenses relate to professional, consulting, advisory, and other fees that are non-recurring. |
Free Cash Flow
Free cash flow represents cash flow from/(used in) operating activities, less additions to property and equipment. We use free cash flow, a non-IFRS financial measure, to assess the amount of cash available for dividend payments, debt repayment and other investing and financing activities. We believe that this information is useful to certain investors and analysts to evaluate the Company’s performance with respect to its operating cash flow capacity to meet non-discretionary outflows of cash. The following table reconciles our cash flow from/(used in) operating activities to free cash flow:
|
Three Months Ended |
|
Six Months Ended |
||
|
June 30, |
|
June 30, |
||
|
2023 |
2022 |
|
2023 |
2022 |
(USD, in thousands) |
$ |
$ |
|
$ |
$ |
Cash flow from (used in) operating activities |
(1,389) |
(10,409) |
|
(7,346) |
(18,001) |
Purchases of property and equipment |
(158) |
(152) |
|
(200) |
(431) |
Free cash flow |
(1,547) |
(10,561) |
|
(7,546) |
(18,432) |
Key Performance Indicators
This press release also makes reference to “Annual Recurring Revenue” or “ARR” and “Annual Recurring Revenue Per Account” or “ARPA”, which are key performance indicators we use to help us evaluate our business, measure our performance, identify trends affecting our business, formulate business plans and make strategic decisions. Our key performance indicators may be calculated in a manner different from similar key performance indicators used by other companies. Definitions of these key performance indicators can be found under the heading “Key Performance Indicators” in the Company’s management’s discussion and analysis for the three months ended March 31, 2023 and 2022.
Forward-Looking Information
This press release contains “forward-looking information” and “forward-looking statements” (collectively, “forward-looking information”) within the meaning of applicable securities laws. In some cases, forward-looking information generally can be identified by the use of terminology such as “expect”, “continue”, “anticipate”, “intend”, “aim”, “plan”, “believe”, “budget”, “estimate”, “forecast”, “foresee”, “close to”, “target” or negative versions thereof and similar expressions.
This forward-looking information relates to our future financial outlook and anticipated events or results and includes, but is not limited to, information regarding: the Company’s financial position, financial results, business strategy, performance, achievements, growth strategies; the Company’s budgets, operations, and taxes; judgments and estimates impacting our financial statements; the market in which the Company operates; industry trends and the Company’s competitive position; expansion of the Company’s product offerings; trends in research and development ("R&D") expenses and general and administrative ("G&A") expenses, each as a percentage of revenue; planned decreases in sales and marketing and R&D activities; the timing and pace for achieving profitability; and expectations regarding the growth of the Company’s client base, revenue and revenue generation potential.
Forward-looking information is based on certain assumptions, expectations and projections, and analyses made by the Company in light of our experience and perception of historical trends, current conditions and expected future developments, as well as other factors that we currently believe are appropriate and reasonable in the circumstances. Despite a careful process to prepare and review the forward-looking information, there can be no assurance that the underlying assumptions, expectations, estimates and assumptions will prove to be correct. Certain assumptions underlying the forward-looking information in this MD&A include: our ability to continue investing in infrastructure to support our growth and brand recognition; our ability to continue maintaining and enhancing our technological infrastructure and the functionality of our platform; our ability to develop and implement new product offerings; our ability to capitalize on growth opportunities and implement our growth strategy; our ability to build our market share and enter new geographies; the total addressable market for our products; our ability to retain key personnel; our ability to maintain existing client relationships and to continue to expand our clients’ use of our platform and products; our ability to maintain existing relationships on similar terms with our current service providers, suppliers, channel partners and other third parties; our ability to maintain and expand our geographic scope; our ability to execute on our expansion plans; our ability to obtain financing on acceptable terms or at all; the impact of competition; the changes and trends in our industry or the global economy; changes in laws, rules, regulations, and global standards; and that the risks and uncertainties noted below will not materialize.
Given these risks or uncertainties, investors are cautioned not to place undue reliance on forward-looking information, including any financial outlook. Any forward-looking information that is contained in this MD&A speaks only as of the date of such statement, and the Company undertakes no obligation to update any forward-looking information or to publicly announce the results of any revisions to any of those statements to reflect future events or developments, except as required by applicable securities laws. Comparisons of results for current and any prior periods are not intended to express any future trends or indications of future performance, unless specifically expressed as such, and should only be viewed as historical data. The opinions, estimates or assumptions referred to above are described in greater detail in "Summary of Factors Affecting our Performance" and should be considered carefully by prospective investors.
Additional information relating to Q4, can be found on SEDAR under the Company’s profile at www.sedar.com.
About Q4 Inc.
Q4 Inc. (TSX: QFOR) is the leading capital markets access platform that is transforming how issuers, investors, and the sell-side efficiently connect, communicate, and engage with each other.
The Q4 Platform facilitates interactions across the capital markets through IR website products, virtual events solutions, engagement analytics, investor relations CRM, shareholder and market analysis, surveillance, and ESG tools. The Q4 Platform is the only holistic capital markets access platform that digitally drives connections, analyzes impact, and targets the right engagement to help public companies work faster and smarter.
The company is a trusted partner to more than 2,600 public companies globally, including many of the most respected brands in the world, and maintains an award winning culture where team members grow and thrive.
Q4 is headquartered in Toronto, with offices in New York and London. Learn more at investors.Q4inc.com.
__________________________
1 Annual recurring revenue or “ARR” is a key performance indicator. See “Key Performance Indicators”
2 Adjusted EBITDA is a non-IFRS measure. See “Non-IFRS Measures and Reconciliation of Non-IFRS Measures”
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230809347184/en/
Contact information
Investors
Edward Miller
Director, Investor Relations
(437) 291-1554
ir@q4inc.com
Media
Heather Noll
Corporate Communications Manager
media@q4inc.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
PUMA Called Ambassadors From All Around the World to Form “Class of 23”1.10.2023 13:00:00 EEST | Press release
Global sports company PUMA launches a beanies campaign, “Class of 23”, to unite ambassadors from across the globe to represent of the close-knit PUMA family. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231001418878/en/ Global sports company PUMA launches a beanies campaign, “Class of 23”, to unite ambassadors from across the globe to represent of the close-knit PUMA family. (Photo: Business Wire) 2023 means a long journey for PUMA, which was made with the remarkable people behind it. “Class of 23” is the right way to celebrate the inspiring ambassadors and talents PUMA has collaborated with over the past 75 years. Each talent, from Neymar Jr. and Pamela Reif to Gianmarco Tamberi and Winnie Harlow, was captured in a personalized way, wearing their favorite PUMA beanies from the 2023 collection to show their membership in the grand PUMA family. “Our PUMA family is the heartbeat of our brand, co-created with the brilliance
Optomind and MaxLinear announce collaboration on PAM4 112Gbps OSFP 800Gbps SR8 transceiver solution at ECOC Exhibition 20231.10.2023 09:00:00 EEST | Press release
Optomind and MaxLinear will be demonstrating 800Gbps OSFP active optical cables (AOC) and SR8 optical transceivers at ECOC 2023 Exhibition, in Glasgow, Scotland, October 2-4 (Booth #775, Optomind; #776, MaxLinear). Optomind has developed the best-in-class PAM4 100Gbps/lane SR optical transceivers and AOCs using MaxLinear's 5nm Keystone PAM4 DSP. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230930086952/en/ Advancing data transmission rates to 100Gbps per lane drastically transforms the ecosystem of data centers, especially AI/ML and HPC. Training AI and GPT workloads drive huge and high-density networks utilizing large numbers of servers connected together through rack switches over short reach links. The low-power, high-performance AOCs and transceivers that Optomind and MaxLinear have developed together are ideal for these applications. Optomind selected MaxLinear's 5nm Keystone PAM4 DSP as the best-in-class solution for
Incyte to Present Multiple Studies from Dermatology Portfolio at 2023 European Academy of Dermatology and Venereology (EADV) Congress29.9.2023 20:43:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced multiple abstracts featuring new data from across its dermatology portfolio have been accepted for presentation at the upcoming European Academy of Dermatology and Venereology (EADV) Congress 2023 held October 11-14 in Berlin. “We are pleased to add to the data supporting the use of ruxolitinib cream for patients living with vitiligo and atopic dermatitis (AD) through two late-breaking presentations – one on prolonged use of treatment in vitiligo patients with limited or no initial response, and the full results of our TRuE-AD3 trial in pediatric AD,” said Jim Lee, M.D., Ph.D., Group Vice President, Inflammation & Autoimmunity, Incyte. “Collectively, the data at this year's Congress, which also include new late-breaking data for povorcitinib in vitiligo, emphasize our ongoing efforts to advance treatment options for the Dermatology community." Key abstracts from Incyte-sponsored programs include: Late-breaking Oral Presentations Vitiligo Efficacy an
Q4 Inc. Recognized as one of Canada’s Top Growing Companies by The Globe and Mail29.9.2023 17:30:00 EEST | Press release
Q4 Inc. (TSX: QFOR) (“Q4” or “the Company”), the leading capital markets access platform, is pleased to announce their ranking on the 2023 Report on Business of Canada’s Top Growing Companies. Canada’s Top Growing Companies ranks Canadian companies on three-year revenue growth. Q4 earned its spot with three-year growth of 150%. “We are honored to be recognized as one of Canada’s Top Growing Companies for the fourth consecutive year by The Globe and Mail,” remarked Darrell Heaps, Founder and CEO of Q4. “We are proud of the growth we have achieved as a company and this recognition is a true reflection of our dedication to helping our clients win in the capital markets through innovative technology on the Q4 Platform.” Canada’s Top Growing Companies is an editorial ranking that was launched in 2019. It aims to bring the accomplishments of innovative businesses in Canada to the forefront. In order to qualify for this voluntary program; companies had to complete an in-depth application proc
GEDi Cube and Renovaro Biosciences Sign Definitive Agreement to Combine29.9.2023 16:15:00 EEST | Press release
GEDi Cube Intl Ltd. (GEDi Cube), an AI medical technology company, and Renovaro Biosciences Inc. (NASDAQ:RENB) (Renovaro), an advanced, preclinical biotechnology firm in cell, gene and immunotherapy, have signed a definitive agreement to combine, in which GEDi Cube will become a wholly-owned subsidiary of Renovaro in a stock-for-stock acquisition (the “Transaction”). If completed, the Transaction will result in a combined company that will offer advanced early diagnosis and early identification of recurring cancer as well as potential therapies for several critical diseases such as pancreatic cancer and other solid tumors with poor life expectancy. The combined company will have a unique advantage: Renovaro Biosciences’ pre-clinical and clinical trial data could be utilized to accelerate GEDi Cube’s AI capabilities that, in turn, could potentially help to accelerate Renovaro’s development of potential new therapies. AI will be used to advance the fields of diagnosis and treatment with
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom